Abbott Revises 2024 Adjusted EPS Guidance To $4.55-$4.70 Versus Prior Guidance Of $4.50-$4.70 And Consensus Of $4.62
Portfolio Pulse from Benzinga Newsdesk
Abbott has updated its 2024 adjusted EPS guidance to a range of $4.55-$4.70, slightly adjusting the lower end from the previous guidance of $4.50-$4.70. This update comes in comparison to a consensus estimate of $4.62.
April 17, 2024 | 11:36 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Abbott has revised its 2024 adjusted EPS guidance, raising the lower end from $4.50 to $4.55, with the upper end remaining at $4.70, against a consensus of $4.62.
Abbott's adjustment of its 2024 EPS guidance, particularly the increase in the lower end, suggests a positive outlook and potential for exceeding market expectations. This revision could lead to increased investor confidence and potentially a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100